Analysis of Molecular Pretreated Tumor Profiles as Predictive Biomarkers of Therapeutic Response and Survival Outcomes after Neoadjuvant Therapy for Rectal Cancer in Moroccan Population

<div>Immunohistochemical expression of pretreatment biomarkers. (a) MSH6 expression showing an unstableness (×400). (b) Expression of 80% of nuclear Ki67 (×400). (c) Nuclear expression of p53 (×20). (d) Expression of HER-2 showing a score 3+ (×20).</div>

Disease Markers

fig2

Figure 2

Figure 2: Analysis of Molecular Pretreated Tumor Profiles as Predictive Biomarkers of Therapeutic Response and Survival Outcomes after Neoadjuvant Therapy for Rectal Cancer in Moroccan Population 

Figure 2 | Analysis of Molecular Pretreated Tumor Profiles as Predictive Biomarkers of Therapeutic Response and Survival Outcomes after Neoadjuvant Therapy for Rectal Cancer in Moroccan Population 